Automated Intracytoplasmic Sperm Injection (ICSIA)

Status unconfirmed · Not applicable

Conditions studied: Infertility, Female

In brief

The purpose of this research study is to evaluate Overture's automated Intracytoplasmic Sperm Injection (ICSIA) System. ICSIA is an investigational medical device that automates injection of sperm into eggs. This study will evaluate survival and fertilization rates of oocytes handled via ICSIA and compare to survival and fertilization rates of oocytes which are manually injected with sperm.

Key facts

Study ID

NCT05633316

Run by

Overture Life

People needed

10

Starts

2022-12-05

Expected to finish

2024-11-30

Last updated by the study team

2023-07-06

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Infertile women undergoing IVF treatment with ICSI

You may not qualify if…

• Severe male factor infertility

Where it is running

• New Hope Fertility Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.